HOME › Press Releases › Medical Membranes Market worth 7.4 Billion USD by 2020
Medical Membranes Market worth 7.4 Billion USD by 2020
The report "Medical Membranes Market Chemistry (PTFE, PVDF, PE, Modified Acrylics and Others), by Technology (Ultrafiltration, Microfiltration, Reverse Osmosis, Dialysis, Gas Separation, Others), by Application (Hemodialysis, Drug delivery, IV Infusion Filters & Sterile Filtration, Others), and Geography - Trends & Forecast to 2020", The global medical membranes market projected to register approximately USD 7.4 Billion by 2020, in terms of value, registering a CAGR of 9.9% between 2015 and 2020. This growth is fueled by the rising number of overweight (obese) individuals and the aging populations and also growth and advancement of the healthcare, pharmaceutical, and biotechnology industries
Browse 77 market tables and 49 figures spread through 128 pages and in-depth TOC on "Medical Membranes Market Chemistry (PTFE, PVDF, PE, Modified Acrylics and Others), by Technology (Ultrafiltration, Microfiltration, Reverse Osmosis, Dialysis, Gas Separation, Others), by Application (Hemodialysis, Drug delivery, IV Infusion Filters & Sterile Filtration, Others), and Geography - Trends & Forecast to 2020"
Early buyers will receive 10% customization on reports.
Growth in biopharmaceuticals and new therapeutics markets is leading the growth of this market in North America and Europe
Membranes are used in the medical industry to meet the increased demand of high purity components. Membranes offer high selectivity and permeability, thus providing additional advantage. The drivers of the medical membranes market in North America and Europe are the rising cost of product development and manufacturing, pharmaceutical price control and competition with generics, more severe clinical trial hurdles, and more stringent environmental regulations.
Germany is the largest market for medical membranes in Europe that is projected to register significant growth between 2015 and 2020. The U.S. is the largest market for medical membranes in North America and it is projected to witness a high growth between 2015 and 2020.
Asia-Pacific countries such as China and India are projected to account for the highest share in the medical membranes market, in terms of value, by 2020
Asia-Pacific is projected to register high growth rate in the medical membranes market in the next five years mainly due to the growing medical market and increasing regulations in the region. Medical membranes are widely used in hemodialysis application. In Asia-Pacific, India and China are two countries with the highest prevalence of diabetes. Higher prevalence of diabetes leads to high incidences of kidney failures; thus, leading to higher demand for hemodialysis in the region. This along with more companies adopting good manufacturing practices for manufacturing pharmaceuticals is driving the demand of medical membranes in the region.
The growth in the healthcare market is majorly driving the medical membranes market in India.
Increasing incidents of diabetes and end-stage renal disease (ESRD) in developing regions such as Asia-Pacific and RoW
The incidents of diabetes and end-stage renal disease (ESRD) are increasing due to the rise in the aging population and the increase in the number of obese people. With this rise, the healthcare, pharmaceutical, and biotechnology industries are also witnessing significant growth in countries such as India and China. India has the world’s largest number of diabetic population and China has the world’s second-largest number of diabetic population. The medical membranes market is projected to register high growth in the Middle East & Africa and Latin America in the next five years due to increased rates of diabetes and advancement of the healthcare market.
The major players such as Asahi Kasei Co. (Japan), Hyflux Ltd. (Singapore), Koch Membranes System (U.S.), Merck Millipore (Canada), Pall Corporation (U.S.), 3M Company (U.S.), and others have adopted development strategies such as acquisitions and product developments to achieve growth in the global medical membranes market.
This report covers the market, by value, for medical membranes and forecasts the market size till 2020. The report includes the market segmentation by chemistry, by applications, by technology, and by region. It also provides company profiles and competitive strategies adopted by the major market players in the global medical membranes market.
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India